Oncology & Cancer

Pediatric cancer drug shows 93 percent response rate

A first-of-its-kind drug targeting a fused gene found in many types of cancer was effective in 93 percent of pediatric patients tested, researchers at UT Southwestern's Simmons Cancer Center announced.

Oncology & Cancer

Global burden of thyroid cancer is increasing

(HealthDay)—There is an increasing global burden of thyroid cancer, according to a study published online June 26 in JAMA Network Open.

Oncology & Cancer

Drop the C-word to reduce anxiety and overtreatment, say experts

Medical researchers are calling for the word 'cancer' to be dropped from some doctor-patient conversations in a bid to reduce patient anxiety and harm from over treatment.The appeal in today's BMJ follows mounting evidence ...

Genetics

Eye color may indicate risk for serious skin conditions

Eye color may be an indicator of whether a person is high-risk for certain serious skin conditions. A study, led by the University of Colorado School of Medicine, shows people with blue eyes are less likely to have vitiligo. ...

Oncology & Cancer

New test for thyroid cancer could prevent unnecessary surgery

Researchers at The University of Texas at Austin and Baylor College of Medicine have developed a new preoperative test for thyroid cancer that is faster and about two-thirds more accurate than the diagnostic tests doctors ...

page 1 from 33